M1 Kliniken AG decides to buy back shares

Publication of inside information pursuant to Art. 17 of Regulation (EU) No. 596/2014

Berlin, 26.04.2024 - The Management Board of M1 Kliniken AG today resolved to repurchase up to 1,000,000 shares of the Company in a total volume not exceeding EUR 12,600,000.00 (excluding incidental acquisition costs). The resolution is based on the authorisation of the Annual General Meeting of 9 July 2020 to acquire own shares. The buyback programme is to start on 29 April 2024 and be completed by the end of 25 April 2025 at the latest. The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company. The sole purpose of the share buyback programme is to use the repurchased shares for all purposes provided for in the authorisation resolution of the Company's Annual General Meeting of 9 July 2020 and for all other purposes permitted under the law governing the Company's shares.

The buy-back programme and its implementation shall take place in compliance with the requirements of the safe harbour regulations pursuant to Art. 5 para. 2 of the Market Abuse Regulation (EU) No. 596/2014 and Art. 2, 3 and 4 of the Delegated Regulation (EU) No. 2016/1052, with the exception of the purpose of the buy-back. This is broader than determined by Art. 5 para. 2 of the Market Abuse Regulation.

Berlin, 03.05.2024 - In the period from 29.04.2024 up to and including 03.05.2024, M1 Kliniken AG has acquired 17.017 shares in the context of its ongoing share buyback programme, which was published by notice dated 26.04.2024 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date

Number of shares

Average price (EUR)

29.04.2024

4.458

13,31

30.04.2024

4.938

13,47

01.05.2024

n.a.

n.a.

02.05.2024

2.098

14,51

03.05.2024

5.523

15,00

Total

17.017

 

 

The total number of shares purchased in the context of the share buy-back program since 29.04.2024 through, and including, 03.05.2024 amounts to 17.017.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).

Berlin, 10.05.2024 - In the period from 06.05.2024 up to and including 10.05.2024, M1 Kliniken AG has acquired 28.948 shares in the context of its ongoing share buyback programme, which was published by notice dated 26.04.2024 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date

Number of shares

Average price (EUR)

06.05.2024

0

0

07.05.2024

6.537

16,50

08.05.2024

7.118

16,00

09.05.2024

7.634

16,26

10.05.2024

7.659

16.36

Total

28.948

 

 

The total number of shares purchased in the context of the share buy-back program since 29.04.2024 through, and including, 10.05.2024 amounts to 45.965.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).

Berlin, 17.05.2024 - In the period from 13.05.2024 up to and including 17.05.2024, M1 Kliniken AG has acquired 40.744 shares in the context of its ongoing share buyback programme, which was published by notice dated 26.04.2024 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date

Number of shares

Average price (EUR)

13.05.2024

7.810

16,05

14.05.2024

7.855

16,44

15.05.2024

8.031

16,54

16.05.2024

8.142

17,51

17.05.2024

8.906

17.68

Total

40.744

 

 

The total number of shares purchased in the context of the share buy-back program since 29.04.2024 through, and including, 17.05.2024 amounts to 86.709.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).